1-4 of 4
P.C. Huijgens, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients:

Jaap Jan Zwaginga, MD, PhD, Ronnie van der Holt, PhD, Bart J. Biemond, MD, PhD, Peter A.W. te Boekhorst, MD, PhD, Mark Levin, MD, PhD, Art Vreughdenhil, MD, PhD, P.C. Huijgens, MD, PhD, Anneke Brand, MD, PhD, Rene van der Griend, MD, PhD, Marleen Luten, Hans Pruijt, MD, PhD, Okke de Weerdt, Elisabeth van Pampus, MD, PhD, Sonja Zweegman, MD, PhD, Rene Hollestein, Harry R. Koene, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2514.
https://doi.org/10.1182/blood.V116.21.2514.2514
Published: 2010
Journal Articles

Cost-Effectiveness of Rituximab for Maintenance in Patients with Follicular Non-Hodgkin’s Lymphoma in the Dutch Setting

Marjolein Pompen, PhD, P.C. Huijgens, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2364.
https://doi.org/10.1182/blood.V112.11.2364.2364
Published: 2008
Journal Articles

Fludarabin/Cyclophosphamide Reduced Intensity Conditioning for Allografting Offers an Excellent Outcome for Heavily Pretreated Lymphoma Patients.

A. Roel Jonkhoff, MD, PhD, J.J.W.M Janssen, MD, O. Visser, MD, H.M. van Roessel, P.C. Huijgens, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5349.
https://doi.org/10.1182/blood.V108.11.5349.5349
Published: 2006
Journal Articles

Phase III Trial of 2-Weekly CHOP with Rituximab for Aggressive B-Cell Non-Hodgkin’s Lymphoma in Elderly Patients.

Pieter Sonneveld, MD, Wim van Putten, MsC, Douwe Biesma, MD, Harald Holte, MD, Marinus van Marwijk Kooij, MD, Mark Henri H. Kramer, MD, P.W. Wijermans, MD, Monique Steijaert, Gustaaf W. van Imhoff, MD, P.J. Lugtenburg, MD, P.C. Huijgens, MD, Mikael Eriksson, MD
Journal: Blood
Blood (2006) 108 (11): 210.
https://doi.org/10.1182/blood.V108.11.210.210
Published: 2006